|
Class action Fosamax lawsuit filed in Canada |
|
Tuesday, 29 May 2007 |
A Canadian woman has filed a class action Fosamax lawsuit against the manufacturer of the osteoporosis drug. The woman alleges that Merck Frosst Canada, the Canadian branch of Merck & Co., failed to adequately warn patients that Fosamax could cause a condition known as osteonecrosis of the jaw (ONJ).
According to her Fosamax lawsuit, the 45-year-old woman used the drug between 2001 and 2004, and was diagnosed with ONJ last year. The condition, also known as “jaw death,” causes the bones in the jaw to rot away and eventually die.
The lawsuit alleges that Merck failed to warn patients of the risk of Fosamax side effects. In December 2004, the company was ordered by Health Canada, the nation’s drug regulatory agency, to add a warning to the labeling of Fosamax alerting patients of the possible risk of developing ONJ from taking the drug.
One of the Fosamax lawyers involved in the case says that a second class action suit will eventually be filed in Quebec on behalf of patients who have suffered Fosamax side effects. No date for this proposed Fosamax lawsuit has been announced. |